Sonia Tejada Solís

Biography

    Graduated in Medicine in 2001. Specialist in Neurosurgery in Hospital Ramón y Cajal from 2002 to 2007.   Doctor in Medicine from the University of Alcalá de Henares on July 12, 2007.   He has made several stays in centers of recognized international prestige:   MD Anderson Cancer Center, Texas. Year 2005. Neurosurgery Service. Specialty in tumors of the central nervous system. With this center it maintains, at the present time, active active from the point of view of investigation (collaboration in clinical and preclinical tests with oncolíticos virus). University Hospital October 12. Year 2006. Neurosurgery Service. Specialization in neurosurgical pediatrics. Fellowship in the use of intraoperative resonance and advanced imaging studies in pediatric neurosurgery. Liverpool AlderHey Hospital. Year 2015. Stay at John Radcliffe Hospital in Oxford for training in endoscopic surgery. Year 2016. Research Areas Research lines: intraoperative magnetic resonance surgery, 5-ALA fluorescence surgery, oncolytic virus treatment and immunotherapy.    In recent years, research projects have focused on finding new treatments for malignant glial tumors of the central nervous system based mainly on immunotherapy: oncolytic virus, dendritic cell vaccines and, currently, immunomodulatory treatment. In addition to trying to improve the surgery of these tumors by the use of fluorescence with 5-ALA and the application of intraoperative resonance to improve resection of brain and spinal tumors.    She has participated in 5 research projects, in 3 of them as principal investigator: "Phase I study of the combination of DNX-2401 oncolytic virus with a short course of temozolomide in the treatment of patients with first glioblastoma relapse . " EudraCT Number: 2011-005935-21. Promoter: Clinical University of Navarra. Principal investigator. Started in September 2013. "Prospective Phase II study of the efficacy and safety of vaccination with autologous dendritic cells in patients with glioblastoma multiforme after complete surgical resection with fluorescence microscopy" EudraCT Number: 2009-009879-35 Research Associate Principal Investigator: Ricardo Díez Department of Neurosurgery, University of Navarra Clinic "Therapeutic planning of glioblastoma by in vivo delimitation of the tumor border by means of PET with 11C-methionine, perfusion MRI and intraoperative fluorescence with 5-ALA."  Collaborative researcher. Principal investigator: Dr. Javier Arbizu Lostao. "Study of fluorescence emitted by tumor cells and normal after administration of 5-aminolevulinic acid: experimental bases of a possible application to grade II and III gliomas .  "  Principal investigator. It ended in 2012. "Retrospective observational study on the effectiveness of gliolan in the treatment of malignant gliomas in Spain" (Estudio Visiona) . Promoted and financed by laboratories Gebro. Principal Investigator within the University of Navarra Clinic. Completed in 2011.   ACTIVITY   As a teacher Professor contracted doctor in the Department of Neurosurgery of the Medicine Faculty. Accreditation by ANECA in May 2014. As researcher He has participated in 19 scientific publications in national and international journals.   He has written more than 20 papers / papers at national and international conferences.

Research Interest

 Improve the surgical treatment of brain tumors in both children and adults.